AGIO SCHEDULE 13G/A: SEC filing

D. E. Shaw & Co., L.P. and David E. Shaw

Filed with the SEC on · accession 0001104659-26-128410

AGIO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. D. E. Shaw & Co., L.P. and David E. Shaw filed an amended Schedule 13G reporting beneficial ownership of 3,888,907 shares, or 6.5%, of Agios Pharmaceuticals common stock as of September 30, 2026. The stock moved -4.6% by the first close after the filing.

Summary of the filing

D. E. Shaw & Co., L.P. and David E. Shaw filed an amended Schedule 13G reporting beneficial ownership of 3,888,907 shares, or 6.5%, of Agios Pharmaceuticals common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

Key details

Shares beneficially owned$3.9M
Shares with shared voting power$3.6M
Percent of class beneficially owned$7
IssuerAgios Pharmaceuticals, Inc.
Reporting person / investment adviserD. E. Shaw & Co., L.P.
Record holder of 1,562,179 sharesD. E. Shaw Valence Portfolios, L.L.C.
Record holder of 1,148,474 sharesD. E. Shaw Oculus Portfolios, L.L.C.
Manager of 1,178,254 sharesD. E. Shaw Investment Management, L.L.C.
President and sole shareholder of d. e. shaw & co., inc.David E. Shaw
Chief compliance officer, d. e. shaw & co., l.p.Daniel R. Marcus

How AGIO stock reacted

Close before

$31.59

Nov 13, 2026

First close after

-4.56%

$30.15

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for AGIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AGIO?

Click here

Frequently asked questions

What did AGIO file with the SEC on Nov 16, 2026?

AGIO filed a SCHEDULE 13G/A (SEC filing). D. E. Shaw & Co., L.P. and David E. Shaw filed an amended Schedule 13G reporting beneficial ownership of 3,888,907 shares, or 6.5%, of Agios Pharmaceuticals common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did AGIO stock react to this filing?

AGIO closed at $31.59 before the filing and $30.15 on Nov 16, 2026 (-4.56%).

Other AGIO SEC filings

Get alerts when AGIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days